Simbiosys

<a href="https://simbiosys.com/">SimBioSys</a> (short for Simulated Biological Systems) is a technology company deploying a combination of artificial intelligence and biophysical simulations to improve the personalized and patient-specific understanding of cancer. 
SimBioSys developed a simulation engine, TumorScope, which utilizes current standard of care diagnostic data (imaging & pathology) to create spatially resolved virtual replicas of an individual tumor and microenvironment and uses mechanistic models to incorporate the major hallmarks of cancer including drug sensitivity & delivery, metabolism, mechanical forces. The simulations enable precise & comprehensive predictions of response to therapy while providing researchers and clinicians keys insights into mechanisms of resistance. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options computationally to truly individualize treatment. 
In the crowded world of genomics, new approaches have many barriers to becoming a new standard of care. SimBioSys complements and/or supersedes current precision medicine techniques while only relying on readily available and previously acquired datasets.

Simbiosys open-in-new

Simbiosys